Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy

Journal of Urology

Volumn 158, Issue 2, 1997, Pages 515-518

  Connolly, John A ^a   Presti Jr , Joseph C ^a   Cher, Michael L ^a   Chew, Karen ^a   Shinohara, Katsuto ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Neoplasm recurrence, local; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0030814801     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64522-1     Document Type: Article

References (14)

1. Connolly, J. A., Shinohara, K., Presti, J. C., Jr. and Carroll, P. R.: Local recurrence after radical prostatectomy: characteristics in size, location and relationship to prostate-specific antigen and surgical margins. Urology, 47: 225, 1996.
2. Stamey, T. A., Ferrari, M. K. and Schmid, H.-P.: The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients. J. Urol., 150: 1856, 1993.
3. Wheeler, J. A., Zagras, G. K. and Ayala, A. G.: Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression. Cancer, 71: 3783, 1993.
4. Ten Kate, F. J. W., Gallee, M. P. W., Schmitz, P. I. M., Joebsis, A. C., Van der Heul, R. O., Prins, M. E. F. and Blom, J. H. M.: Problems in grading of prostatic carcinoma: interobserver variability of five different grading systems. World J. Urol., 4: 147, 1986.
5. Colin, M. B., Waldman, F. M., Carroll, P. R., Kerschmann R., Chew, K. and Mayall, B. H.: Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Hum. Path., 24: 772, 1993.
6. Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U. and Stein, H.: Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133: 1710, 1984.
7. Cher, M. L., Chew, K., Rosenau, W. and Carroll, P. R.: Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Prostate, 26: 87, 1995.
8. Gallee, M. P. W., Visser-de Jong, E., Ten Kate, F. J. W., Schroeder, F. H. and van der Kwast, T. H. H.: Monoclonal antibody ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer. J. Urol., 142: 1342, 1989.
9. Epstein, J. I. Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993.
10. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
11. Leibman, B.D., Dillioglugil, O., Rogers, E., Kattan, M.W., Seale-Hawkins, C., Wolfinger, R. and Scardino, P.T.: Analyzing PSA trends in recurrent patients after radical prostatectomy and radiotherapy (XRT): a novel analysis. J. Urol., part 2, 155: 698a, abstract 1550, 1996.
12. Carroll, P. R., Waldman, F. M., Rosenau, W., Cohen, M. B., Vapnek, J. M., Fong, P., Narayan, P. and Mayall, B. H.: Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression. J. Urol., 149: 403, 1993.
13. Li, X., James, W. M., Traganos, F. and Darzynkiewicz, Z.: Application of biotin, digoxigenin or fluorescein conjugated deoxynucleotides to label DNA strand breaks for analysis of cell proliferation and apoptosis using flow cytometry. Biotech. Histochem., 70: 234, 1995.
14. Bubendorf, L., Sauter, G., Moch, H., Jordan, P., Blochlinger, A., Gasser, T. C. and Mihatsch, M. J.: Prognostic significance of Bcl-2 in clinically localized prostate cancer. Amer. J. Path., 148: 1557, 1996.